CAR T-cell therapy (Novartis)

N/A

Report date: 2025/03/14 16:51:11

Base Information

Drug NameCAR T-cell therapy (Novartis)

Drug Alias NameCAR T-cell therapy (Intellia Therapeutics/Novartis)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIntellia Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag

Inactive CompaniesIntellia Therapeutics Inc

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A